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Abstract
We sought to find significant gene × gene interaction in a genome-wide association analysis of
rheumatoid arthritis (RA) by performing pair-wise tests of interaction among collections of single-
nucleotide polymorphisms (SNPs) obtained by one of two methods. The first method involved
screening the results of the genome-wide association analysis for main effects p-values < 1 × 10-4. The
second method used biological databases such as the Gene Ontology and Kyoto Encyclopedia of Genes
and Genomes to define gene collections that each contained one of four genes with known associations
with RA: PTPN22, STAT4, TRAF1, and C5. We used a permutation approach to determine whether any
of these SNP sets had empirical enrichment of significant interaction effects. We found that the SNP set
obtained by the first method was significantly enriched with significant interaction effects (empirical p =
0.003). Additionally, we found that the “protein complex assembly” collection of genes from the Gene
Ontology collection containing the TRAF1 gene was significantly enriched with interaction effects with
p-values < 1 × 10-8 (empirical p = 0.012).
Introduction
Genome-wide association studies (GWAS) are routinely
used in the search for genes associated with complex
traits. Often, a test of association with a phenotype of
interest is performed for each single-nucleotide poly-
morphism (SNP) independently and pair-wise tests of
interaction are used to find gene × gene interaction. In
GWAS, performing all pair-wise interaction tests can be
an intractable task, especially if logistic regression with
covariate adjustments is used. It is imperative to develop
strategies to search out gene × gene interaction in the
context of GWAS. In this paper, we apply two screening
approaches to reduce the number of tests performed.
The strongest known genetic association with rheuma-
toid arthritis (RA) is the HLA-DRB1 locus, which is part
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of the major histocompatibility complex on chromo-
some 6. After performing a GWAS analysis that adjusted
for SNPs capturing the strong association signal from the
HLA-DRB1 locus, we used a permutation approach to
evaluate sets of candidate SNPs to determine if these sets
yielded an excess of significant main effects and SNP ×
SNP interaction effects over what would be expected by
chance.
We defined candidate sets of SNPs using two methods.
The first method, suggested by Kooperberg and Leblanc
[1], tests for pair-wise interaction between SNPs with
significant main effects, defined here as having main
effect p-values less than 1 × 10-4. In the second method,
we used biological processes to define gene collections
and searched for significant main effects and pair-wise
interaction effects among SNPs near these genes. We
sought to evaluate this gene-based approach in collec-
tions containing at least one of four genes having known
associations with RA: PTPN22 [2,3], STAT4 [4], TRAF1,
and C5 [5]. After a set of SNPs from either of these two
methods was found to have empirical enrichment of
significant interaction effects in models unadjusted for
the HLA-DRB1 locus, we then evaluated pairwise
interactions adjusting for SNPs that capture the signal
from the HLA-DRB1 locus.
Methods
Study sample and genotyping
The study sample for this research consists of 2,062
individuals in the North American Rheumatoid Arthritis
Consortium (NARAC), 868 who had RA and 1,194 who
did not. Genotyping of the sample was performed on
Infinium HumanHap550 arrays, version 1.0 (Illumina)
and is described elsewhere [5]. In total, genotypes for
545,080 SNPs were made available to our study. The
analysis of this data was performed as part of the Genetic
Analysis Workshop 16.
The study sample and genotype data were cleaned using
utilities in the PLINK software package, version 1.02 [6].
Individuals were removed from the sample if their reported
sex did not match their estimated sex given their genotypes
on the X chromosome. Additional individual-level clean-
ing consisted of checking the number of missing genotypes
per person, a test of missingness by case-control status, and
a haplotype test for non-random missing genotypes with
respect to case-control status. SNPs were removed from the
analysis if the call rate was less than 95%, the minor allele
frequency was less than 1%, the Hardy-Weinberg equili-
brium p-value was less than 10-4, or a test for differential
missingness between cases and controls resulted in a
p-value < 10-4. After filtering, the sample consisted of
2,055 individuals and 495,766 SNPs.
Statistical analysis
Statistical analyses were performed using PLINK, version
1.02 [6] and the statistical package R, version 2.6.1. The
association between each SNP and RA was assessed with
logistic regression adjusting for sex and specific genetic
loci as described below. In the case of the gene-centric
analysis, we defined sets of SNPs as described below and
used PLINK to perform tests of main effects and
interaction with these SNPs. The pair-wise tests of
interactions for the permutations described below were
performed using the–fast-epistasis command in PLINK.
Sets of SNPs that were enriched with significant pair-wise
interactions were further evaluated using logistic regres-
sion models in R, which included SNPs explaining the
association signals in the HLA-DRB1 locus.
Adjusting for HLA-DRB1
It is well known that specific alleles at the HLA-DRB1
locus in 6p21 are strongly associated with RA. The
literature suggests two classes of alleles: the highest risk
alleles are DRB1*0401, 0404, 0405, 0408, and 0409, and
other risk alleles are DRB1*0101, 0102, 0104, 0105,
1001, 1402, and 1406 [7]. In our genome-wide search for
significant interacting and main effects we performed
analyses adjusting for the number of high risk and other
risk alleles for each individual.
After adjusting for the HLA-DRB1 locus, highly signifi-
cant SNPs remained in the 6p21 region surrounding the
HLA-DRB1 locus. We added SNPs to our model, one at a
time, until the most significant SNP on chromosome 6
was no longer in the 6p21 region.
Enrichment of interaction effects among SNPs with
significant main effects
Kooperberg and Leblanc [1] suggest that there is more
power to detect gene × gene interaction effects if tests for
interaction are limited to those SNPs with significant
main effects, thus limiting the number of tests per-
formed. We defined statistical significance of main
effects using a p-value cut-off of 1 × 10-4, a less
conservative choice than the Bonferroni significance
cut-off of 0.05/545,080 = 9.17 × 10-7. We then
performed pair-wise interaction tests among all SNPs
that passed quality control filters and had statistically
significant main effects. Significance of interaction
p-values was determined with a Bonferroni correction
on the number of tests performed.
In order to determine whether this set of SNPs was enriched
with more significant interaction effects than would be
expected by chance, we employed a permutation approach
to construct a null distribution for the proportion of
interaction p-values less than the alpha level determined
BMC Proceedings 2009, 3(Suppl 7):S81 http://www.biomedcentral.com/1753-6561/3/S7/S81
Page 2 of 6
(page number not for citation purposes)
by the Bonferroni correction. We permuted the phenotype
and covariates of our sample 1,000 times. For each
permutation, we performed a genome-wide scan of single-
SNP association, chose those SNPs with p-values < 10-4, and
performed pair-wise interaction tests with this set of SNPs.
The null distribution from which we determine significant
enrichment of interaction p-values was built from the
number of tests with p-values less than the Bonferroni
correction from each permutation.
Enrichment of main and interaction effects
among SNPs in gene collections
Four genes that are known to be associated with RA are
PTPN22, STAT4, TRAF1, and C5. In the case of TRAF1 and
C5, a SNP was found to be associated with RA and is in
linkage disequilibrium with both the TRAF1 and C5 genes;
the causal variant(s) among these genes have yet to be
determined. We identified pathways and gene collections
containing these four genes from two sources: the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [8-10] and
the Gene Ontology (GO) project [11]. Two genes were
found in KEGG pathways. The TRAF1 gene is in the “small
cell lung cancer” pathway and STAT4 is in the “JAK-STAT
signaling” pathway. We used GO data sets to extract sets to
which our genes are annotated in the Biological Process
ontology. To avoid overly narrow or broad sets, we focused
on GO sets that contained at least 30, but no more than
220, genes. We considered the following GO sets: “protein
amino acid dephosphorylation” for PTPN22; “JAK-STAT
cascade” for STAT4; “protein complex assembly” for
TRAF1; “activation of MAPK activity”, “chemotaxis”, and
“inflammatory response” for the C5 gene.
In the analysis of each gene collection, we used a
permutation approach to determine whether the gene
collection was significantly enriched with p-values < 10-6,
10-7, and 10-8. The phenotypes of our sample were
permuted and pair-wise tests of interaction were performed
with the SNPs in the gene collection. The observed number
of SNPs with main effect p-values < 10-6, 10-7, and 10-8 was
noted for each permutation, as was the number of pair-
wise interaction tests with p-values below the same
thresholds. A null distribution of both main effect and
interaction p-values below each threshold was built from
1,000 permutations. Significant enrichment of main effect
and interaction p-values was determined by comparing the
proportion of p-values less than each threshold in the set of
SNPs in the gene collection with the empirical null
distribution at that threshold.
Results
Adjusting for HLA-DRB1
Our analysis of main effect associations of SNPs was
adjusted for the HLA-DRB1 locus on 6p24, using two
covariates indicating the number of risk alleles per
person as well as five SNPs in the immediate vicinity
of the gene. These SNPs, with their gene and p-value
from the adjusted model are: rs9391858 (C6orf10, 1.7 ×
10-33), rs660895 (HLA-DRB1, 7.7 × 10-19), rs2395175
(HLA-DRA, 5.1 × 10-16), rs2524123 (HLA-C, 9.3 × 10-8),
and rs3130237 (COL11A2, 1.62 × 10-8). From the same
model, the variable indicating the number of high-risk
HLA-DRB1 alleles and the variable indicating the
number of other risk alleles had p-values of 0.017 and
0.79, respectively. After applying this adjusted model on
all other chromosome 6 SNPs, the most significant SNP
was rs11964472 (p-value 1.8 × 10-6), located near the
PAQR8 and MCM3 genes on 6p12.
Pair-wise interaction tests among these four SNPs and
the number of HLA-DRB1 risk alleles indicate that no
significant interaction exists among the four SNPs in the
adjusted model or the number of HLA-DRB1 risk alleles.
Enrichment of interaction effects among SNPs with
significant main effects
We sought to find significant SNP × SNP interactions
among the SNPs with significant main effects after
adjustment for the number of high-risk HLA-DRB1
alleles, the number of other risk alleles, and the five
SNPs near the HLA-DRB1 locus. Of the genome-wide
SNPs passing quality control filters, 178 had main effect
p-values < 10-4.
This set of SNPs was significantly enriched with
interaction p-values < 10-4 based on permutation tests.
We performed 15,383 unadjusted pair-wise interaction
tests with these SNPs. Using a Bonferroni correction, the
p-value cut-off for significance would be 0.05/15,383 =
3.25 × 10-6. Of the 15,383 unadjusted pair-wise tests,
two tests had p-values < 3.17 × 10-6 with a permutation
p-value of 0.003, indicating significant enrichment of
interaction effects in this set of SNPs. In the adjusted
models, which adjust for the strong signal in HLA-DRB1,
the most significant interaction effect occurred between
rs1333914 in DBC1 on chromosome 9 and C6orf10 on
chromosome 6, with an interaction p-value of 5.7 × 10-5.
The top ten results of the adjusted pair-wise interaction
analyses are presented in Table 1.
Enrichment of main and interaction effects among SNPs
in gene collections
Using sets of SNPs in biologically derived gene collec-
tions, we used permutations to establish the significance
of the proportion of main effects and interaction effects
below certain p-value thresholds. The results of this
analysis are presented in Table 2. Of interest are two gene
collections that contain the TRAF1 gene. SNPs near
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TRAF1 account for the most significant signals in the
GWAS (rs2900180, p = 2.1 × 10-9) after adjusting for the
HLA-DRB1 locus. The “small cell lung cancer” KEGG
pathway, which contains the TRAF1 gene, is significantly
enriched with significant main effect p-values, but not
with significant interaction effects. The enrichment of
main effects p-values is driven by the significant SNPs in
the TRAF1 gene. On the other hand, the “protein
complex assembly” set of SNPs from GO is significantly
enriched with both significant main effects and interac-
tion effects. Two genes in this set, TRAF1 and TAP2, have
significant main effects after adjusting for the HLA-DRB1
locus, which is very close to the HLA-DRB1 locus. Among
the SNPs within 60 kb of the TAP2 gene, unadjusted
interaction p-values were as low as 1 × 10-20. Such high
significance is most likely due to the unadjusted nature
of the tests for interaction using the–fast-epistasis
command in PLINK: SNPs within TAP2 capture the
strong signal present in the region.
We subsequently studied the pair-wise interaction
between SNPs in the “protein complex assembly” gene
collection using logistic regression models that adjusted
for the HLA-DRB1 locus. Because there are a large
Table 1: Top ten pair-wise interaction results among SNPs with main-effects p-values < 1 × 10-4 from logistic regression models
SNP 1 Chr Position (1,000 bp) Closest gene SNP 2 Chr Position (1,000 bp) Closest gene Interaction p-value
rs1333914 9 121623 DBC1 rs9391858a 6 32449 C6orf10 5.7 × 10-5
rs9368950 6 36736 CDKN1A rs9408926 9 122955 CEP110 5.7 × 10-5
rs3873444 6 32791 HLA-DQA2 rs17172185 7 43253 HECW1 1.1 × 10-4
rs9368950 6 36736 CDKN1A rs9408928 9 122992 RAB14 1.9 × 10-4
rs7679231 4 137102 PCDH18 rs8017455 14 80645 TSHR 2.4 × 10-4
rs532098 6 32686 HLA-DRB1 rs660895a 6 32685 HLA-DRB1 2.6 × 10-4
rs4674520 2 201422 CLK1 rs2524123a 6 31373 HLA-C 3.3 × 10-4
rs10948693 6 52262 MCM3 rs7330752 13 29755 KATNAL1 3.8 × 10-4
rs4674520 2 201427 CLK1 rs10948693 6 52262 MCM3 4.0 × 10-4
aSNPs from the adjusted model.
Table 2: Number of tests with p-values < 10-6, 10-7, 10-8
No. p-Values below thresholda
(permutation p-value)
SNP set Source RA gene
included in set
No. genes in
set
Testb N tests <10-6 <10-7 <10-8
Small cell lung cancer KEGG TRAF1 87 Main effects 3,429 6 (<0.001) 6 (<0.001) 3 (<0.001)
Interaction 5,800,955 8 (0.081) 0 (1) 0 (1)
JAK-STAT signaling
pathway
KEGG STAT4 153 Main effects 3,253 0 (1) 0 (1) 0 (1)
Interaction 5,169,188 7 (0.137) 3 (0.029) 0 (1)
Protein complex
assembly
GO TRAF1 214 Main effects 3,883 6 (<0.001) 6 (<0.001) 3 (<0.001)
Interaction 7,277,905 292 (0.642) 193
(0.152)
151 (0.012)
Protein amino acid
dephosphorylation
GO PTPN22 73 Main effects 2,277 0 (1) 0 (1) 0 (1)
Interaction 2,496,978 1 (0.735) 0 (1) 0 (1)
JAK-STAT cascade GO STAT4 41 Main effects 761 0 (1) 0 (1) 0 (1)
Interaction 289,031 0 (1) 0 (1) 0 (1)
Activation of MAPK
activity
GO C5 47 Main effects 785 3 (<0.001) 3 (<0.001) 1 (<0.001)
Interaction 307,355 0 (1) 0 (1) 0 (1)
Chemotaxis GO C5 112 Main effects 1,470 3 (<0.001) 3 (<0.001) 1 (<0.001)
Interaction 1,065,328 1 (0.467) 0 (1) 0 (1)
Inflammatory
response
GO C5 180 Main effects 2,535 3 (<0.001) 3 (<0.001) 1 (<0.001)
Interaction 3,163,945 8 (0.025) 0 (1) 0 (1)
aEmpirical significance was determined by comparing the number of p-values below each threshold to a null distribution of the number obtained by
permuting the phenotypes and performing main effects and interaction tests with the permuted data set.
bInteraction tests are unadjusted.
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number of genes and SNPs in this collection (214 and
3,883 respectively), we filtered the number of SNPs by
main effects p-values = 0.20 and r2 > 0.5, for a total of
572 SNPs. The top ten results observed among these tests
are presented in Table 3.
Discussion
We found that the set of SNPs with significant main
effects was enriched with significant interaction effects,
using an interaction p-value cut-off of 3.17 × 10-6. In
using biological information from the KEGG and GO
databases, significant enrichment of low-interaction
p-values was observed when genes such as TRAF1 and
TAP2 were included in the gene sets. These genes were
close to the most significant regions in the GWAS. None
of the other gene sets were found to be enriched with
significant main effects or pair-wise interactions.
Despite these promising findings, both methods of
selecting SNPs for tests of interactions have disadvan-
tages. When selecting SNPs with significant main effects,
those interactions among SNPs without main effects will
be missed. The justification for the approach is the gain
in power by testing fewer SNPs. The power to detect
interaction in the absence of main effects is very low
when tests of interaction are performed in the entire
genome due to the number of tests being performed. In
the selection of SNPs using “expert knowledge” from
biological databases, the quality of the gene sets is only
as good as the quality of the database. The curation of
these databases is a developing science and there are
many reasons to believe that the quality of these
resources and the data they provide will continue to
improve.
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